National Office for Cancer Prevention and Control, National Cancer Center, Beijing 100021, China.
Chin J Cancer Res. 2014 Feb;26(1):48-58. doi: 10.3978/j.issn.1000-9604.2014.01.08.
Population-based cancer registration data in 2010 were collected, evaluated and analyzed by the National Central Cancer Registry (NCCR) of China. Cancer incident new cases and cancer deaths were estimated.
There were 219 cancer registries submitted cancer incidence and death data in 2010. All data were checked and evaluated on basis of the criteria of data quality from NCCR. Total 145 registries' data were qualified and accepted for cancer statistics in 2010. Pooled data were stratified by urban/rural, area, sex, age group and cancer site. Cancer incident cases and deaths were estimated using age-specific rates and national population. The top ten common cancers in different groups, proportion and cumulative rate were also calculated. Chinese census in 2000 and Segi's population were used for age-standardized incidence/mortality rates.
All 145 cancer registries (63 in urban and 82 in rural) covered a total of 158,403,248 population (92,433,739 in urban and 65,969,509 in rural areas). The estimates of new cancer incident cases and cancer deaths were 3,093,039 and 1,956,622 in 2010, respectively. The morphology verified cases (MV%) accounted for 67.11% and 2.99% of incident cases were identified through death certifications only (DCO%) with mortality to incidence ratio (M/I) of 0.61. The crude incidence rate was 235.23/100,000 (268.65/100,000 in males, 200.21/100,000 in females), age-standardized incidence rates by Chinese standard population (ASIRC, 2000) and by world standard population (ASIRW) were 184.58/100,000 and 181.49/100,000 with the cumulative incidence rate (0-74 years old) of 21.11%. The cancer incidence and ASIRC were 256.41/100,000 and 187.53/100,000 in urban areas whereas in rural areas, they were 213.71/100,000 and 181.10/100,000, respectively. The crude cancer mortality in China was 148.81/100,000 (186.37/100,000 in males and 109.42/100,000 in females), age-standardized incidence rates by Chinese standard population (ASMRC, 2000) and by world standard population (ASMRW) were 113.92/100,000 and 112.86/100,000, and the cumulative incidence rate (0-74 years old) was 12.78%. The cancer mortality and ASMRC were 156.14/100,000 and 109.21/100,000 in urban areas, whereas in rural areas, they were 141.35/100,000 and 119.00/100,000 respectively. Lung cancer, gastric cancer, colorectal cancer, liver cancer, esophageal cancer, pancreas cancer, encephaloma, lymphoma, female breast cancer and cervical cancer, were the most common cancers, accounting for 75% of all cancer cases in urban and rural areas. Lung cancer, gastric cancer, liver cancer, esophageal cancer, colorectal cancer, pancreatic cancer, breast cancer, encephaloma, leukemia and lymphoma accounted for 80% of all cancer deaths.
The coverage of cancer registration population had a rapid increase and could reflect cancer burden in each area and population. As the basis of cancer control program, cancer registry plays an irreplaceable role in cancer epidemic surveillance, evaluation of cancer control programs and making anti-cancer strategy. China is facing serious cancer burden and prevention and control should be enhanced.
中国国家癌症中心(NCCR)收集、评估和分析了 2010 年的基于人群的癌症登记数据。估计了癌症发病新病例和癌症死亡人数。
共有 219 个癌症登记处提交了 2010 年的癌症发病率和死亡率数据。根据 NCCR 的数据质量标准,对所有数据进行了检查和评估。共有 145 个登记处的数据合格并被接受用于 2010 年的癌症统计。根据城乡、地区、性别和年龄组以及癌症部位对汇总数据进行分层。使用年龄特异性发病率和全国人口估算癌症发病例数和死亡人数。还计算了不同组别的十大常见癌症、比例和累积率。使用 2000 年中国人口普查和 Segi 人口进行年龄标准化发病率/死亡率。
所有 145 个癌症登记处(城市 63 个,农村 82 个)共覆盖 158403248 人(城市 92433739 人,农村 65969509 人)。2010 年新发癌症发病例数和癌症死亡例数的估计值分别为 3093039 例和 1956622 例。形态学验证病例(MV%)占发病例数的 67.11%,仅有死亡证明的病例(DCO%)占 2.99%,死亡率与发病率之比(M/I)为 0.61。粗发病率为 235.23/100000(男性 268.65/100000,女性 200.21/100000),中国标准人口(2000 年)和世界标准人口(ASIRW)年龄标准化发病率(ASIRC)分别为 184.58/100000 和 181.49/100000,0-74 岁累积发病率为 21.11%。癌症发病率和 ASIRC 在城市地区分别为 256.41/100000 和 187.53/100000,而在农村地区分别为 213.71/100000 和 181.10/100000。中国粗癌症死亡率为 148.81/100000(男性 186.37/100000,女性 109.42/100000),中国标准人口(2000 年)和世界标准人口(ASMRW)年龄标准化死亡率(ASMRC)分别为 113.92/100000 和 112.86/100000,0-74 岁累积死亡率为 12.78%。癌症死亡率和 ASMRC 在城市地区分别为 156.14/100000 和 109.21/100000,而在农村地区分别为 141.35/100000 和 119.00/100000。肺癌、胃癌、结直肠癌、肝癌、食管癌、胰腺癌、脑癌、淋巴瘤、女性乳腺癌和宫颈癌是最常见的癌症,占城乡所有癌症病例的 75%。肺癌、胃癌、肝癌、食管癌、结直肠癌、胰腺癌、乳腺癌、脑癌、白血病和淋巴瘤占所有癌症死亡人数的 80%。
癌症登记人口的覆盖范围迅速增加,可以反映各地区和人群的癌症负担。作为癌症控制计划的基础,癌症登记在癌症流行监测、癌症控制计划评估和制定抗癌策略方面发挥着不可替代的作用。中国面临着严重的癌症负担,应加强预防和控制。